Study guide
3.3 Corticosteroids & Other Hormonal Agents
DHA Pharmacist Licensing Assessment PHO5481
Track your progress as you read
Finished sections get a check mark.
1 Exam Overview & Licensing Pathway
1.1 Current Exam Facts & Format 1.2 Eligibility, PQR & the Sheryan Application Process 1.3 Study Strategy & Test-Day Plan
2 Cardiovascular Pharmacology
2.1 Antihypertensives & RAAS Agents 2.2 Heart Failure & Antiarrhythmic Drugs 2.3 Lipid-Lowering & Antianginal Agents
3 Endocrine & Metabolic Pharmacology
3.1 Insulin & Oral Antidiabetic Agents 3.2 Thyroid, Bone & Calcium Agents 3.3 Corticosteroids & Other Hormonal Agents
4 Anti-Infective Pharmacology
4.1 Beta-Lactam Antibiotics 4.2 Non-Beta-Lactam Antibacterials 4.3 Antifungals, Antivirals & Antituberculars
5 CNS, Psychiatric & Pain Pharmacology
5.1 Psychiatric Pharmacology 5.2 Antiepileptics & Neurologic Agents 5.3 Analgesics: NSAIDs, Opioids & Migraine
6 Respiratory, GI & Hematology Pharmacology
6.1 Respiratory Pharmacology 6.2 Gastrointestinal Pharmacology 6.3 Anticoagulants, Antiplatelets & Hematology Agents
7 Pharmaceutical Care: Cardiometabolic Disease
7.1 Diabetes Management & Counseling 7.2 Hypertension & Dyslipidemia Management 7.3 Heart Failure & Anticoagulation Management
8 Pharmaceutical Care: Respiratory, Rheumatology & Infection
8.1 Asthma & COPD Management 8.2 Gout, Pain & Rheumatologic Care 8.3 Infection Management & Antimicrobial Stewardship
9 Counseling, Monitoring & Special Populations
9.1 Patient Counseling, Adherence & Health Literacy 9.2 Therapeutic Monitoring & Laboratory Interpretation 9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment 9.4 Pharmacoeconomics & Formulary Decision Making
10 Pharmaceutical Calculations I
10.1 Concentration, Ratio & Percentage Strength 10.2 Weight-Based & BSA Dosing 10.3 Dilution, Concentration & Alligation
11 Pharmaceutical Calculations II
11.1 Infusion Rates & IV Flow Calculations 11.2 Dispensing Quantities & Days' Supply 11.3 Compounding Calculations, Isotonicity & Milliequivalents
12 UAE Pharmacy Law & Regulation
12.1 UAE Regulatory Framework & Licensing Authorities 12.2 Medicine Registration, Pricing & Supply Chain 12.3 Prescription Requirements & Validity
13 Controlled Drugs, Ethics & Pharmacovigilance
13.1 Controlled & Semi-Controlled Medicines in the UAE 13.2 Ethics, Confidentiality & Generic Substitution 13.3 Pharmacovigilance, Recall & Medicine Disposal
14 Pharmacokinetics I: ADME
14.1 Absorption & Bioavailability 14.2 Distribution & Protein Binding 14.3 Metabolism & Elimination
15 Pharmacokinetics II: Kinetics, Dosing & TDM
15.1 Half-Life, Clearance & Kinetic Order 15.2 Loading & Maintenance Dosing 15.3 Therapeutic Drug Monitoring
16 OTC Medicines & Self-Care
16.1 Cough, Cold & Allergic Rhinitis 16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea 16.3 Pain & Fever Self-Care 16.4 Referral Red Flags, Emergency Contraception & Skin
17 Medication Safety
17.1 High-Alert Medications & Error-Prone Abbreviations 17.2 Medication Reconciliation & Duplicate Therapy 17.3 Adverse Drug Reactions & Hypersensitivity Recognition
18 Sterile & Nonsterile Compounding
18.1 Aseptic Technique & Compounding Environments 18.2 Parenteral, TPN & Cytotoxic Preparation 18.3 Nonsterile Compounding
19 Pharmaceutics, Biopharmaceutics & Toxicology
19.1 Dosage Form Design & the Biopharmaceutics Classification System 19.2 Dissolution & Excipients 19.3 Toxicology: Poisoning Recognition & Antidotes
20 Infection Control, Natural Products, Medicinal Chemistry & Pharmacogenomics
20.1 Infection Control & Immunization 20.2 Pharmacognosy & Dietary Supplements 20.3 Medicinal Chemistry Essentials 20.4 Clinical Pharmacogenomics
3.3 Corticosteroids & Other Hormonal Agents
Key Takeaways Explain This Topic AI
Dexamethasone is roughly 25-30 times as glucocorticoid-potent as hydrocortisone with negligible mineralocorticoid activity; hydrocortisone has the strongest mineralocorticoid effect
Systemic glucocorticoids used for more than 3 weeks suppress the HPA axis and must be tapered — abrupt withdrawal risks adrenal crisis; give stress-dose steroids during illness or surgery
Inhaled corticosteroids cause oral candidiasis and dysphonia — counsel patients to rinse the mouth and spit after each use
Estrogen-containing contraceptives raise VTE risk and lose efficacy with enzyme inducers such as rifampicin and carbamazepine; ulipristal works up to 120 hours, levonorgestrel up to 72 hours
- Desmopressin's key danger is hyponatremia from water retention — counsel fluid restriction and monitor sodium
- Last updated: August 2026
3.3 Corticosteroids & Other Hormonal Agents
Hormonal agents reward precise knowledge: potency conversions, withdrawal dangers and counseling details are classic exam material.
Systemic Glucocorticoids
Glucocorticoids such as prednisolone and dexamethasone bind intracellular glucocorticoid receptors to suppress inflammatory gene transcription. Agents differ in potency, mineralocorticoid (salt-retaining) activity and duration:
- Agent Equivalent dose Relative glucocorticoid potency Mineralocorticoid activity Duration
- Hydrocortisone 20 mg 1 High Short
- Prednisolone 5 mg 4 Moderate Intermediate
- Methylprednisolone 4 mg 5 Low Intermediate
- Dexamethasone 0.75 mg ~25-30 Negligible Long
Hydrocortisone's strong mineralocorticoid activity suits adrenal replacement; dexamethasone's long duration and negligible salt retention suit cerebral edema and antiemetic regimens but make HPA suppression more likely.
For once-daily dosing, give glucocorticoids in the morning to mimic the natural cortisol rhythm and limit insomnia and HPA suppression; alternate-day regimens further reduce toxicity in some chronic indications. High-dose immunosuppressive therapy contraindicates live vaccines , and blood glucose should be monitored because steroid-induced hyperglycemia can unmask or worsen diabetes.
HPA-axis suppression and tapering: systemic courses longer than about 3 weeks (or repeated short courses) suppress the hypothalamic-pituitary-adrenal (HPA) axis . Such patients must never stop abruptly — doses are tapered gradually to let endogenous cortisol recover, and patients carry a steroid card. During intercurrent illness, trauma or surgery they need stress-dose (sick-day) steroids ; failure to supplement can precipitate an adrenal crisis — hypotension, hypoglycemia, hyponatremia and collapse — treated with immediate parenteral hydrocortisone and fluids.
Adverse effects and mitigation: hyperglycemia (steroid-induced diabetes), immunosuppression with masking of infection, osteoporosis (provide calcium/vitamin D and consider a bisphosphonate in at-risk patients on long-term therapy), gastrointestinal bleeding especially with concurrent non-steroidal anti-inflammatory drugs (NSAIDs) — consider proton pump inhibitor (PPI) cover — plus weight gain and Cushingoid features, hypertension, cataracts and glaucoma, mood changes or psychosis, myopathy and growth suppression in children.
Inhaled Corticosteroids
Inhaled agents (beclomethasone, budesonide, fluticasone) act locally in the airways with minimal systemic exposure at standard doses. The characteristic adverse effects are local: oral candidiasis (thrush) and dysphonia (hoarseness) . Counsel patients to rinse the mouth with water and spit after each use and to use a spacer with metered-dose inhalers; high doses over long periods can still cause systemic effects.
Combined Oral Contraceptives
Combined oral contraceptives (COCs) contain an estrogen (usually ethinylestradiol) plus a progestogen and prevent ovulation by suppressing follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The estrogen component raises venous thromboembolism (VTE) risk; COCs are contraindicated with previous VTE, smoking at age 35 or over, migraine with aura, uncontrolled hypertension, and a BMI of 35 or above. Missed-pill rules (concept): one missed pill — take it as soon as remembered and continue the pack, no extra precautions; two or more missed — take the most recent pill, continue the pack, use condoms for 7 days, and consider emergency contraception if pills were missed in the first week after unprotected sex. Enzyme inducers — rifampicin, carbamazepine, phenytoin and St John's Wort — accelerate hormone metabolism and reduce efficacy, requiring alternative or additional contraception.
Non-contraceptive benefits of COCs include lighter, more regular menses and reduced dysmenorrhea, acne, and ovarian and endometrial cancer risk. Breakthrough bleeding is common in the first few cycles and does not usually signal reduced efficacy when pills are taken correctly.
Emergency Contraception
Levonorgestrel 1.5 mg (a progestogen) is licensed up to 72 hours after unprotected intercourse and works best the sooner it is taken; high body weight or BMI may reduce its efficacy. Ulipristal acetate 30 mg , a selective progesterone receptor modulator, remains effective up to 120 hours by delaying ovulation; because it competes with progestogens, patients should wait 5 days before starting or resuming hormonal contraception and use condoms meanwhile. If vomiting occurs within about 2-3 hours of either agent, the dose should be repeated. The copper intrauterine device is the most effective emergency contraception overall.
Hormone Replacement Therapy
Hormone replacement therapy (HRT) for menopausal symptoms uses estrogen alone in women without a uterus, and combined estrogen plus progestogen when the uterus is present, because unopposed estrogen drives endometrial hyperplasia. Prescribe the lowest effective dose with regular review. Oral estrogen increases VTE and stroke risk; transdermal preparations avoid first-pass hepatic effects and carry a lower VTE risk. Long-term combined HRT slightly increases breast cancer risk. HRT is most appropriate for vasomotor symptoms in women under 60 or within 10 years of menopause, where benefit generally outweighs risk; it is not started primarily for chronic disease prevention.
Desmopressin
Desmopressin is a synthetic analog of antidiuretic hormone (ADH, vasopressin) selective for V2 receptors, reducing renal free-water excretion. It treats central (cranial) diabetes insipidus , primary nocturnal enuresis, and — at higher doses — mild hemophilia A and von Willebrand disease by releasing stored factor VIII. Its defining hazard is hyponatremia and water intoxication : counsel patients to restrict fluids during treatment, monitor serum sodium (especially in the elderly and when starting), and withhold doses during illnesses causing fluid or electrolyte imbalance. Symptoms of hyponatremia — headache, nausea, confusion, seizures — warrant urgent review. Intravenous desmopressin is also used perioperatively in mild hemophilia A and von Willebrand disease; tachyphylaxis develops with repeated dosing as factor VIII stores become depleted.